menu
    • menu

    Company profile for Inhibrx

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inhibrx is a clinical stage biologic immunotherapeutic company focused on the treatment of high unmet medical needs in oncology, infectious disease and inflammatory conditions. Inhibrx’s proprietary platforms enable fit-for-function biotherapeutics that optimally interface with the biology of each target antigen to focus and conditionally modulate immune activities and mediate enhanced signaling. Therapeutic proteins include...
    Inhibrx is a clinical stage biologic immunotherapeutic company focused on the treatment of high unmet medical needs in oncology, infectious disease and inflammatory conditions. Inhibrx’s proprietary platforms enable fit-for-function biotherapeutics that optimally interface with the biology of each target antigen to focus and conditionally modulate immune activities and mediate enhanced signaling. Therapeutic proteins include multispecific and multivalent molecules designed and crafted using our composite modular single domain antibody technology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InhibrxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Torrey Pines Science Park 11025 N Torrey Pines Rd #200 La Jolla, CA 92037
    Telephone
    Telephone
    (858) 795-4220
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inhibrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inhibrx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inhibrx Reports First Quarter 2026 Financial Results
    Inhibrx Reports First Quarter 2026 Financial Results

    15 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-reports-first-quarter-2026-financial-results-302772832.html

    PR NEWSWIRE
    15 May 2026
    Share Share
    Inhibrx Combo Outperforms Keytruda in Tumor Shrinkage
    Inhibrx Combo Outperforms Keytruda in Tumor Shrinkage

    11 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-reports-interim-phase-2-data-for-inbrx-106-in-first-line-hnscc-initial-results-demonstrate-potential-costimulatory-benefit-over-pd-1-monotherapy-302767819.html

    PR NEWSWIRE
    11 May 2026
    Share Share
    Inhibrx to Host Webcast on INBRX-106 HexAgon First-Line HNSCC
    Inhibrx to Host Webcast on INBRX-106 HexAgon First-Line HNSCC

    09 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-to-host-webcast-presentation-to-provide-clinical-update-on-inbrx-106-hexagon-study-in-first-line-hnscc-302767267.html

    PR NEWSWIRE
    09 May 2026
    Share Share
    Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda
    Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda

    25 Apr 2026

    // REUTERS

    https://www.reuters.com/world/merck-rivals-eye-deal-inhibrx-experimental-cancer-drug-tied-keytruda-sources-say-2026-04-22/

    REUTERS
    25 Apr 2026
    Share Share
    Inhibrx Update on Ozekibart in Late Line Colorectal Cancer
    Inhibrx Update on Ozekibart in Late Line Colorectal Cancer

    23 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-provides-clinical-update-on-ozekibart-inbrx-109-in-late-line-colorectal-cancer-302749118.html

    PR NEWSWIRE
    23 Apr 2026
    Share Share
    Inhibrx to Webcast Update on Ozekibart in Colorectal Cancer
    Inhibrx to Webcast Update on Ozekibart in Colorectal Cancer

    20 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-to-host-webcast-presentation-to-provide-clinical-update-on-ozekibart-inbrx-109-in-late-line-colorectal-cancer-302747780.html

    PR NEWSWIRE
    20 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search